FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Robert Hirschfeld

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Procedures

Co-author Network

Publications

TOP 3
Robert M A Hirschfeld
Depression epidemiology and its treatment evolution.
Lawrence J Cohen; Larry Culpepper; David A Flockhart; Robert M A Hirschfeld; David A Sclar; Michael E Thase; Chad M VanDenBerg
Discussion: a fresh look at monoamine oxidase inhibitors for depression.
Robert M A Hirschfeld
The epidemiology of depression and the evolution of treatment.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Robert Hirschfeld (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Robert M A Hirschfeld
Depression epidemiology and its treatment evolution.
The Journal of clinical psychiatry 2012;73(10):e29.
2012: Lawrence J Cohen; Larry Culpepper; David A Flockhart; Robert M A Hirschfeld; David A Sclar; Michael E Thase; Chad M VanDenBerg
Discussion: a fresh look at monoamine oxidase inhibitors for depression.
The Journal of clinical psychiatry 2012;73 Suppl 1():42-5.
2012: Robert M A Hirschfeld
The epidemiology of depression and the evolution of treatment.
The Journal of clinical psychiatry 2012;73 Suppl 1():5-9.
2011: Robert M A Hirschfeld
Deep brain stimulation for treatment-resistant depression.
The American journal of psychiatry 2011;168(5):455-6.
2008: David E Kemp; Robert M A Hirschfeld; Stephen J Ganocy; Omar Elhaj; Renee Slembarski; Sarah Bilali; Carla Conroy; James Pontau; Robert L Findling; Joseph Calabrese
Screening for bipolar disorder in a county jail at the time of criminal arrest.
Journal of psychiatric research 2008;42(9):778-86.
2008: Philip B Mitchell; Guy M Goodwin; Gordon F Johnson; Robert M A Hirschfeld
Diagnostic guidelines for bipolar depression: a probabilistic approach.
Bipolar disorders 2008;10(1 Pt 2):144-52.
2008: Rif S el-Mallakh; Terence A Ketter; Richard H Weisler; Robert M A Hirschfeld; Andrew J Cutler; Thomas Gazda; Paul E Keck; Alan C Swann; Amir Kalali
Switching from other agents to extended-release carbamazepine in acute mania.
Psychopharmacology bulletin 2008;41(1):52-8.
2007: Martin B Keller; Madhukar H Trivedi; Michael E Thase; Richard C Shelton; Susan G Kornstein; Charles Nemeroff; Edward S Friedman; Alan J Gelenberg; James H Kocsis; David L Dunner; Boadie W Dunlop; Robert M A Hirschfeld; Anthony J Rothschild; James M Ferguson; Alan F Schatzberg; John M Zajecka; Ron Pedersen; Bing Yan; Saeeduddin Ahmed; Michael Schmidt; Philip T Ninan
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases.
Biological psychiatry 2007;62(12):1371-9.
2007: Robert M A Hirschfeld
Screening for bipolar disorder.
The American journal of managed care 2007;13(7 Suppl):S164-9.
2007: Martin B Keller; Madhukar H Trivedi; Michael E Thase; Richard C Shelton; Susan G Kornstein; Charles Nemeroff; Edward S Friedman; Alan J Gelenberg; James H Kocsis; David L Dunner; Robert M A Hirschfeld; Anthony J Rothschild; James M Ferguson; Alan F Schatzberg; John M Zajecka; Ronald D Pedersen; Bing Yan; Saeeduddin Ahmed; Jeff Musgnung; Philip T Ninan
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases.
The Journal of clinical psychiatry 2007;68(8):1246-56.
2007: James H Kocsis; Michael E Thase; Madhukar H Trivedi; Richard C Shelton; Susan G Kornstein; Charles Nemeroff; Edward S Friedman; Alan J Gelenberg; David L Dunner; Robert M A Hirschfeld; Anthony J Rothschild; James M Ferguson; Alan F Schatzberg; John M Zajecka; Ronald D Pedersen; Bing Yan; Saeed Ahmed; Jeff Musgnung; Philip T Ninan; Martin B Keller
Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study.
The Journal of clinical psychiatry 2007;68(7):1014-23.
2007: Kathleen Ries Merikangas; Hagop S Akiskal; Jules Angst; Paul E Greenberg; Robert M A Hirschfeld; Maria Petukhova; Ronald C Kessler
Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication.
Archives of general psychiatry 2007;64(5):543-52.
2007: Trisha Suppes; Susan L McElroy; Robert M A Hirschfeld
Awareness of metabolic concerns and perceived impact of pharmacotherapy in patients with bipolar disorder: a survey of 500 US psychiatrists.
Psychopharmacology bulletin 2007;40(2):22-37; quiz 38-40.
2007: Ronald C Kessler; Hagop S Akiskal; Minnie Ames; Howard G Birnbaum; Paul E Greenberg; Robert M A Hirschfeld; Philip S Wang
Considering the costs of bipolar depression.
Behavioral healthcare 2007;27(1):45-7.
2006: Ronald C Kessler; Hagop S Akiskal; Jules Angst; Margaret Guyer; Robert M A Hirschfeld; Kathleen Ries Merikangas; Paul E Stang
Validity of the assessment of bipolar spectrum disorders in the WHO CIDI 3.0.
Journal of affective disorders 2006;96(3):259-69.
2006: Richard C Shelton; Kirsten L Haman; Mark H Rapaport; Ari Kiev; Ward T Smith; Robert M A Hirschfeld; R Bruce Lydiard; John M Zajecka; David L Dunner
A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorder.
The Journal of clinical psychiatry 2006;67(11):1674-81.
2006: Ronald C Kessler; Hagop S Akiskal; Minnie Ames; Howard G Birnbaum; Paul Greenberg; Robert M A Hirschfeld; Robert Jin; Kathleen Ries Merikangas; Gregory E Simon; Philip S Wang
Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers.
The American journal of psychiatry 2006;163(9):1561-8.
2006: Karen Dineen Wagner; Robert M A Hirschfeld; Graham J Emslie; Robert L Findling; Barbara L Gracious; Michael L Reed
Validation of the Mood Disorder Questionnaire for bipolar disorders in adolescents.
The Journal of clinical psychiatry 2006;67(5):827-30.
2006: Hagop S Akiskal; Nael Kilzieh; Jack D Maser; Paula J Clayton; Pamela J Schettler; M Traci Shea; Jean Endicott; William A Scheftner; Robert M A Hirschfeld; Martin B Keller
The distinct temperament profiles of bipolar I, bipolar II and unipolar patients.
Journal of affective disorders 2006;92(1):19-33.
2006: Roy H Perlis; Jeffrey Welge; Lana A Vornik; Robert M A Hirschfeld; Paul E Keck
Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials.
The Journal of clinical psychiatry 2006;67(4):509-16.
2006: Robert M A Hirschfeld; Richard H Weisler; Shane R Raines; Wayne Macfadden
Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled study.
The Journal of clinical psychiatry 2006;67(3):355-62.
2006: Michael Allen; Robert M A Hirschfeld; Patricia Wozniak; Jeffrey D Baker; Charles L Bowden
Linear relationship of valproate serum concentration to response and optimal serum levels for acute mania.
The American journal of psychiatry 2006;163(2):272-5.
2006: Joseph Calabrese; David J Muzina; David E Kemp; Gary S Sachs; Mark A Frye; Thomas R Thompson; David Klingman; Michael L Reed; Robert M A Hirschfeld
Predictors of bipolar disorder risk among patients currently treated for major depression.
MedGenMed : Medscape general medicine 2006;8(3):38.
2006: Richard H Weisler; Robert M A Hirschfeld; Andrew J Cutler; Thomas Gazda; Terence A Ketter; Paul E Keck; Alan Swann; Amir Kalali
Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trials.
CNS drugs 2006;20(3):219-31.
2006: Robert M A Hirschfeld
Introduction: an overview of the issues surrounding the recognition and management of bipolar disorder and comorbid anxiety.
The Journal of clinical psychiatry 2006;67 Suppl 1():3-4.
2006: Robert M A Hirschfeld; Mariëlle Eerdekens; Amir Kalali; Carla M Canuso; Akbar A Khan; Keith Karcher; Joseph M Palumbo
An open-label extension trial of risperidone monotherapy in the treatment of bipolar I disorder.
International clinical psychopharmacology 2006;21(1):11-20.
2005: Mark A Frye; Joseph Calabrese; Michael L Reed; Karen Dineen Wagner; Lydia Lewis; James McNulty; Robert M A Hirschfeld
Use of health care services among persons who screen positive for bipolar disorder.
Psychiatric services (Washington, D.C.) 2005;56(12):1529-33.
2005: Lana A Vornik; Robert M A Hirschfeld
Bipolar disorder: quality of life and the impact of atypical antipsychotics.
The American journal of managed care 2005;11(9 Suppl):S275-80.
2005: Alan Ettinger; Michael L Reed; Joseph F Goldberg; Robert M A Hirschfeld
Prevalence of bipolar symptoms in epilepsy vs other chronic health disorders.
Neurology 2005;65(4):535-40.
2005: Robert M A Hirschfeld; Laura J Fochtmann; John S McIntyre
Antidepressants for bipolar depression.
The American journal of psychiatry 2005;162(8):1546-7; author reply 1547-8.
2005: Trisha Suppes; Ellen B Dennehy; Robert M A Hirschfeld; Lori L Altshuler; Charles L Bowden; Joseph Calabrese; M Lynn Crismon; Terence A Ketter; Gary S Sachs; Alan C Swann
The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder.
The Journal of clinical psychiatry 2005;66(7):870-86.
2005: Robert M A Hirschfeld
Are depression and bipolar disorder the same illness?
The American journal of psychiatry 2005;162(7):1241-2.
2005: Robert M A Hirschfeld; Alvah R Cass; Devin C L Holt; Carol A Carlson
Screening for bipolar disorder in patients treated for depression in a family medicine clinic.
The Journal of the American Board of Family Practice / American Board of Family Practice 2005;18(4):233-9.
2005: Robert M A Hirschfeld; Lana A Vornik
Bipolar disorder--costs and comorbidity.
The American journal of managed care 2005;11(3 Suppl):S85-90.
2005: Hagop S Akiskal; Matthew A Fuller; Robert M A Hirschfeld; Paul E Keck; Terence A Ketter; Richard H Weisler
Reassessing carbamazepine in the treatment of bipolar disorder: clinical implications of new data.
CNS spectrums 2005;10(6):suppl 1-11; discuss 12-3; quiz 14-5.
2005: Dennis A Revicki; Robert M A Hirschfeld; Eileen P Ahearn; Richard H Weisler; Cynthia Palmer; Paul E Keck
Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial.
Journal of affective disorders 2005;86(2-3):183-93.
2005: Robert M A Hirschfeld; Craig H Mallinckrodt; Thomas C Lee; Michael Detke
Time course of depression-symptom improvement during treatment with duloxetine.
Depression and anxiety 2005;21(4):170-7.
2004: Robert M A Hirschfeld; Siegfried Kasper
A review of the evidence for carbamazepine and oxcarbazepine in the treatment of bipolar disorder.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2004;7(4):507-22.
2004: Joseph Calabrese; Robert M A Hirschfeld; Mark A Frye; Michael L Reed
Impact of depressive symptoms compared with manic symptoms in bipolar disorder: results of a U.S. community-based sample.
The Journal of clinical psychiatry 2004;65(11):1499-504.
2004: Alan J Gelenberg; Richard C Shelton; Paul Crits-Christoph; Martin B Keller; David L Dunner; Robert M A Hirschfeld; Michael E Thase; James M Russell; R Bruce Lydiard; Robert Gallop; Linda Todd; David J Hellerstein; Paul J Goodnick; Gabor I Keitner; Stephen M Stahl; Uriel Halbreich; Heather S Hopkins
The effectiveness of St. John's Wort in major depressive disorder: a naturalistic phase 2 follow-up in which nonresponders were provided alternate medication.
The Journal of clinical psychiatry 2004;65(8):1114-9.
2004: Robert M A Hirschfeld; Paul E Keck; Michelle Kramer; Keith Karcher; Carla M Canuso; Mariëlle Eerdekens; Fred Grossman
Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial.
The American journal of psychiatry 2004;161(6):1057-65.
2004: Robert M A Hirschfeld
Bipolar depression: the real challenge.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2004;14 Suppl 2():S83-8.
2004: Robert M A Hirschfeld; Lana A Vornik
Recognition and diagnosis of bipolar disorder.
The Journal of clinical psychiatry 2004;65 Suppl 15():5-9.
2004: Robert M A Hirschfeld; Lana A Vornik
Newer antidepressants: review of efficacy and safety of escitalopram and duloxetine.
The Journal of clinical psychiatry 2004;65 Suppl 4():46-52.
2004: Nidal J Moukaddam; Robert M A Hirschfeld
Intravenous antidepressants: a review.
Depression and anxiety 2004;19(1):1-9.
2003: Alan J Gelenberg; Madhukar H Trivedi; A John Rush; Michael E Thase; Robert H Howland; Daniel N Klein; Susan G Kornstein; David L Dunner; John Markowitz; Robert M A Hirschfeld; Gabor I Keitner; John M Zajecka; James H Kocsis; James M Russell; Ivan Miller; Rachel Manber; Bruce A Arnow; Barbara O Rothbaum; Melvin Munsaka; Phillip Banks; Frances E Borian; Martin B Keller
Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression.
Biological psychiatry 2003;54(8):806-17.
2003: Robert M A Hirschfeld; Jeffrey D Baker; Patricia Wozniak; Katherine A Tracy; Kenneth W Sommerville
The safety and early efficacy of oral-loaded divalproex versus standard-titration divalproex, lithium, olanzapine, and placebo in the treatment of acute mania associated with bipolar disorder.
The Journal of clinical psychiatry 2003;64(7):841-6.
2003: Laszlo Gyulai; Charles L Bowden; Susan L McElroy; Joseph Calabrese; Frederick Petty; Alan C Swann; James C-Y Chou; Adel Wassef; Craig S Risch; Robert M A Hirschfeld; Charles Nemeroff; Paul E Keck; Dwight L Evans; Patricia J Wozniak
Maintenance efficacy of divalproex in the prevention of bipolar depression.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2003;28(7):1374-82.
2003: James M Russell; Susan G Kornstein; M Tracie Shea; James P McCullough; Wilma M Harrison; Robert M A Hirschfeld; Martin B Keller
Chronic depression and comorbid personality disorders: response to sertraline versus imipramine.
The Journal of clinical psychiatry 2003;64(5):554-61.
2003: Joseph Calabrese; Robert M A Hirschfeld; Michael Reed; Marilyn A Davies; Mark A Frye; Paul E Keck; Lydia Lewis; Susan L McElroy; James P McNulty; Karen Dineen Wagner
Impact of bipolar disorder on a U.S. community sample.
The Journal of clinical psychiatry 2003;64(4):425-32.
2003: Robert M A Hirschfeld; Lydia Lewis; Lana A Vornik
Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder.
The Journal of clinical psychiatry 2003;64(2):161-74.
2003: Robert M A Hirschfeld
Long-term side effects of SSRIs: sexual dysfunction and weight gain.
The Journal of clinical psychiatry 2003;64 Suppl 18():20-4.
2003: Robert M A Hirschfeld
The efficacy of atypical antipsychotics in bipolar disorders.
The Journal of clinical psychiatry 2003;64 Suppl 8():15-21.
2003: Robert M A Hirschfeld; Joseph Calabrese; Myrna M Weissman; Michael Reed; Marilyn A Davies; Mark A Frye; Paul E Keck; Lydia Lewis; Susan L McElroy; James P McNulty; Karen Dineen Wagner
Screening for bipolar disorder in the community.
The Journal of clinical psychiatry 2003;64(1):53-9.
2003: Robert M A Hirschfeld; Charles Holzer; Joseph Calabrese; Myrna Weissman; Michael Reed; Marilyn Davies; Mark A Frye; Paul Keck; Susan L McElroy; Lydia Lewis; Jonathan Tierce; Karen Dineen Wagner; Elizabeth Hazard
Validity of the mood disorder questionnaire: a general population study.
The American journal of psychiatry 2003;160(1):178-80.
2002: Robert M A Hirschfeld; Stuart A Montgomery; Eugenio Aguglia; Mario Amore; Pedro Delgado; Markus Gastpar; Christopher Hawley; Siegfried Kasper; Michael Linden; Juan Massana; Julien Mendlewicz; Hans-Jürgen Möller; Charles Nemeroff; Jerónimo Saiz; Pedro Such; Riccardo Torta; Marcio Versiani
Partial response and nonresponse to antidepressant therapy: current approaches and treatment options.
The Journal of clinical psychiatry 2002;63(9):826-37.
2002: John M Zajecka; David L Dunner; Alan J Gelenberg; Robert M A Hirschfeld; Susan G Kornstein; Philip T Ninan; A John Rush; Michael E Thase; Madhukar H Trivedi; Bruce A Arnow; Frances E Borian; Rachel Manber; Martin B Keller
Sexual function and satisfaction in the treatment of chronic major depression with nefazodone, psychotherapy, and their combination.
The Journal of clinical psychiatry 2002;63(8):709-16.
2002: Robert M A Hirschfeld
The use of mirtazapine in difficult-to-treat patient populations.
Human psychopharmacology 2002;17 Suppl 1():S33-6.
2002: Trisha Suppes; Ellen B Dennehy; Alan C Swann; Charles L Bowden; Joseph Calabrese; Robert M A Hirschfeld; Paul E Keck; Gary S Sachs; M Lynn Crismon; Marcia G Toprac; Steven P Shon
Report of the Texas Consensus Conference Panel on medication treatment of bipolar disorder 2000.
The Journal of clinical psychiatry 2002;63(4):288-99.
2002: Michael E Thase; A John Rush; Robert H Howland; Susan G Kornstein; James H Kocsis; Alan J Gelenberg; Alan F Schatzberg; Lorrin M Koran; Martin B Keller; James M Russell; Robert M A Hirschfeld; Lisa M LaVange; Daniel N Klein; Jan Fawcett; Wilma Harrison
Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depression.
Archives of general psychiatry 2002;59(3):233-9.
2002: Robert M A Hirschfeld; David L Dunner; Gabor I Keitner; Daniel N Klein; Lorrin M Koran; Susan G Kornstein; John Markowitz; Ivan Miller; Charles Nemeroff; Philip T Ninan; A John Rush; Alan F Schatzberg; Michael E Thase; Madhukar H Trivedi; Frances E Borian; Paul Crits-Christoph; Martin B Keller
Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination.
Biological psychiatry 2002;51(2):123-33.
2002: David S Baldwin; Dwight L Evans; Robert M A Hirschfeld; Siegfried Kasper
Can we distinguish anxiety from depression?
Psychopharmacology bulletin 2002;36 Suppl 2():158-65.
2002: Christer Allgulander; Robert M A Hirschfeld; David J Nutt
Long-term treatment strategies in anxiety disorders.
Psychopharmacology bulletin 2002;36 Suppl 2():79-92.
2002: Jack M Gorman; Robert M A Hirschfeld; Philip T Ninan
New developments in the neurobiological basis of anxiety disorders.
Psychopharmacology bulletin 2002;36 Suppl 2():49-67.
2001: David J Kupfer; K N Roy Chengappa; Alan J Gelenberg; Robert M A Hirschfeld; J F Goldberg; Gary S Sachs; Victoria J Grochocinski; Patricia R Houck; A B Kolar
Citalopram as adjunctive therapy in bipolar depression.
The Journal of clinical psychiatry 2001;62(12):985-90.
2001: Lorrin M Koran; Alan J Gelenberg; Susan G Kornstein; Robert H Howland; R A Friedman; Charles DeBattista; D Klein; James H Kocsis; Alan F Schatzberg; Michael E Thase; A John Rush; Robert M A Hirschfeld; Lisa M LaVange; Martin B Keller
Sertraline versus imipramine to prevent relapse in chronic depression.
Journal of affective disorders 2001;65(1):27-36.
2001: Richard C Shelton; Martin B Keller; Alan J Gelenberg; David L Dunner; Robert M A Hirschfeld; Michael E Thase; J Russell; R Bruce Lydiard; P Crits-Cristoph; Robert Gallop; L Todd; David J Hellerstein; Paul J Goodnick; Gabor I Keitner; Stephen M Stahl; Uriel Halbreich
Effectiveness of St John's wort in major depression: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2001;285(15):1978-86.
2001: Robert M A Hirschfeld
Bipolar spectrum disorder: improving its recognition and diagnosis.
The Journal of clinical psychiatry 2001;62 Suppl 14():5-9.
2001: James M Russell; Lorrin M Koran; J Rush; Robert M A Hirschfeld; Wilma Harrison; Edward S Friedman; Sonia M Davis; M Keller
Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression.
Depression and anxiety 2001;13(1):18-27.
2000: Robert M A Hirschfeld; J B Williams; R L Spitzer; Joseph Calabrese; L Flynn; Paul E Keck; Lydia Lewis; Susan L McElroy; Robert M Post; D J Rapport; James M Russell; Gary S Sachs; John M Zajecka
Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire.
The American journal of psychiatry 2000;157(11):1873-5.
2000: Charles L Bowden; Joseph Calabrese; Susan L McElroy; Laszlo Gyulai; A Wassef; Frederick Petty; H G Pope; J C Chou; Paul E Keck; LJ Rhodes; Alan C Swann; Robert M A Hirschfeld; Patricia J Wozniak
A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group.
Archives of general psychiatry 2000;57(5):481-9.
2000: Robert M A Hirschfeld; S A Montgomery; Martin B Keller; Siegfried Kasper; Alan F Schatzberg; Hans-Jürgen Möller; D Healy; D Baldwin; Mats Humble; Marcio Versiani; R Montenegro; M Bourgeois
Social functioning in depression: a review.
The Journal of clinical psychiatry 2000;61(4):268-75.
2000: Robert M A Hirschfeld
Suicide and antidepressant treatment.
Archives of general psychiatry 2000;57(4):325-6.
2000: Robert M A Hirschfeld
Sertraline in the treatment of anxiety disorders.
Depression and anxiety 2000;11(4):139-57.
2000: Robert M A Hirschfeld
History and evolution of the monoamine hypothesis of depression.
The Journal of clinical psychiatry 2000;61 Suppl 6():4-6.
1999: Robert M A Hirschfeld; Michael Allen; J P McEvoy; P E Keck; James M Russell
Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patients.
The Journal of clinical psychiatry 1999;60(12):815-8.
1999: Robert M A Hirschfeld
Efficacy of SSRIs and newer antidepressants in severe depression: comparison with TCAs.
The Journal of clinical psychiatry 1999;60(5):326-35.
1999: Robert M A Hirschfeld
Personality disorders and depression: comorbidity.
Depression and anxiety 1999;10(4):142-6.
1999: Robert M A Hirschfeld
Care of the sexually active depressed patient.
The Journal of clinical psychiatry 1999;60 Suppl 17():32-5; discussion 46-8.
1999: B K Boyarsky; W Haque; M R Rouleau; Robert M A Hirschfeld
Sexual functioning in depressed outpatients taking mirtazapine.
Depression and anxiety 1999;9(4):175-9.
1999: Robert M A Hirschfeld
Management of sexual side effects of antidepressant therapy.
The Journal of clinical psychiatry 1999;60 Suppl 14():27-30; discussion 31-5.
1998: Robert M A Hirschfeld; James M Russell; Pedro Delgado; Jan Fawcett; R A Friedman; Wilma M Harrison; Lorrin M Koran; Ivan W Miller; Michael E Thase; Robert H Howland; M A Connolly; RJ Miceli
Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine.
The Journal of clinical psychiatry 1998;59(12):669-75.
1998: Martin B Keller; James H Kocsis; Michael E Thase; Alan J Gelenberg; A John Rush; Lorrin M Koran; Alan F Schatzberg; J Russell; Robert M A Hirschfeld; D Klein; James P McCullough; JA Fawcett; Susan G Kornstein; Lisa M LaVange; Wilma Harrison
Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial.
JAMA : the journal of the American Medical Association 1998;280(19):1665-72.
1998: Martin B Keller; Alan J Gelenberg; Robert M A Hirschfeld; A John Rush; Michael E Thase; James H Kocsis; John Markowitz; JA Fawcett; Lorrin M Koran; Daniel N Klein; James M Russell; Susan G Kornstein; James P McCullough; Sonia M Davis; Wilma M Harrison
The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine.
The Journal of clinical psychiatry 1998;59(11):598-607.
1998: A John Rush; Lorrin M Koran; Martin B Keller; John Markowitz; Wilma M Harrison; RJ Miceli; JA Fawcett; Alan J Gelenberg; Robert M A Hirschfeld; Daniel N Klein; James H Kocsis; James P McCullough; Alan F Schatzberg; Michael E Thase
The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies.
The Journal of clinical psychiatry 1998;59(11):589-97.
1998: Robert M A Hirschfeld
American health care systems and depression: the past, present, and the future.
The Journal of clinical psychiatry 1998;59 Suppl 20():5-10.
1998: J M Martinez; James M Russell; Robert M A Hirschfeld
Tolerability of oral loading of divalproex sodium in the treatment of acute mania.
Depression and anxiety 1998;7(2):83-6.
1998: Robert M A Hirschfeld
Sexual dysfunction in depression: disease- or drug-related?
Depression and anxiety 1998;7 Suppl 1():21-3.
1998: Robert M A Hirschfeld
Long-term nature of depression.
Depression and anxiety 1998;7 Suppl 1():1-4.
1997: Robert M A Hirschfeld; James M Russell
Assessment and treatment of suicidal patients.
The New England journal of medicine 1997;337(13):910-5.
1997: Martin B Keller; Robert M A Hirschfeld; D Hanks
Double depression: a distinctive subtype of unipolar depression.
Journal of affective disorders 1997;45(1-2):65-73.
1997: Robert M A Hirschfeld; W Winslade; T L Krause
Protecting subjects and fostering research. Striking the proper balance.
Archives of general psychiatry 1997;54(2):121-3.
1997: Charles L Bowden; Alan C Swann; Joseph Calabrese; Susan L McElroy; D Morris; Frederick Petty; Robert M A Hirschfeld; Laszlo Gyulai
Maintenance clinical trials in bipolar disorder: design implications of the divalproex-lithium-placebo study.
Psychopharmacology bulletin 1997;33(4):693-9.
1997: Robert M A Hirschfeld
Pharmacotherapy of borderline personality disorder.
The Journal of clinical psychiatry 1997;58 Suppl 14():48-52; discussion 53.
1996: Charles Holzer; H T Nguyen; Robert M A Hirschfeld
Reliability of diagnosis in mood disorders.
The Psychiatric clinics of North America 1996;19(1):73-84.
1996: Daniel N Klein; J H Kocsis; James P McCullough; Charles Holzer; Robert M A Hirschfeld; Martin B Keller
Symptomatology in dysthymic and major depressive disorder.
The Psychiatric clinics of North America 1996;19(1):41-53.
1996: M Tracie Shea; Robert M A Hirschfeld
Chronic mood disorder and depressive personality.
The Psychiatric clinics of North America 1996;19(1):103-20.
1996: Robert M A Hirschfeld
Panic disorder: diagnosis, epidemiology, and clinical course.
The Journal of clinical psychiatry 1996;57 Suppl 10():3-8; discussion 9-10.
1996: Robert M A Hirschfeld
Placebo response in the treatment of panic disorder.
Bulletin of the Menninger Clinic 1996;60(2 Suppl A):A76-86.
1995: Martin B Keller; Daniel N Klein; Robert M A Hirschfeld; James H Kocsis; James P McCullough; I Miller; M B First; C P Holzer; Gabor I Keitner; D B Marin
Results of the DSM-IV mood disorders field trial.
The American journal of psychiatry 1995;152(6):843-9.
1995: Robert M A Hirschfeld
The impact of health care reform on social phobia.
The Journal of clinical psychiatry 1995;56 Suppl 5():13-7.
1995: Martin B Keller; W Harrison; J A Fawcett; Alan J Gelenberg; Robert M A Hirschfeld; D Klein; James H Kocsis; James P McCullough; A John Rush; Alan F Schatzberg
Treatment of chronic depression with sertraline or imipramine: preliminary blinded response rates and high rates of undertreatment in the community.
Psychopharmacology bulletin 1995;31(2):205-12.
1994: Robert M A Hirschfeld
Guidelines for the long-term treatment of depression.
The Journal of clinical psychiatry 1994;55 Suppl():61-9; discussion 70-1.
1994: Robert M A Hirschfeld; Charles Holzer
Depressive personality disorder: clinical implications.
The Journal of clinical psychiatry 1994;55 Suppl():10-7.
1992: Robert M A Hirschfeld
Current perspectives on panic disorder and major depression.
The Journal of clinical psychiatry 1992;53 Suppl():3-4.
1991: Robert M A Hirschfeld
Depressive illness: diagnostic issues.
Bulletin of the Menninger Clinic 1991;55(2):144-55.